HIV mutation literature information.


  Trends of Transmitted and Acquired Drug Resistance in Europe From 1981 to 2019: A Comparison Between the Populations of Late Presenters and Non-late Presenters.
 PMID: 35495657       2022       Frontiers in microbiology
Abstract: The most prevalent TDR drug resistance mutations, in both LP and NLP, were K103N/S, T215rev, T215FY, M184I/V, M41I/L, M46I/L, and L90M.


  Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients.
 PMID: 35082353       2022       Scientific reports
Introduction: Following the Stanford algorithm (mutation list), minor resistance mutations (L10F, V11I, K20TV, L23I, L33F, K43T, F53L, Q58E, A71IL, Discussion: Protease mutation L90M had the strongest correlation with L449F which is confirmed in the dendrogram.
Discussion: These major protease mutations I50V and L90M would therefore be a sentinel for the L449F in the Gag gene.


  Diversity of HIV-1 Subtypes and Transmitted Drug-resistance Mutations Among Minority HIV-1 Variants in a Turkish Cohort.
 PMID: 34802406       2022       Current HIV research
Abstract: M41L, L74I, K65R, M184V, and M184I related to NRTI, K103N to NNRTI, and N83D, M46I, I84V, V82A, L24I, L90M, I54V to the PI sites were identified using NGS.


  Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes.
 PMID: 34873084       2022       AIDS (London, England)
Table: L90M


  Brief Report: Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials.
 PMID: 34897227       2022       Journal of acquired immune deficiency syndromes (1999)
Table: L90M


  Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
 PMID: 35061671       2022       PloS one
Discussion: The most frequent PI DRMs included M46I and L90M, which are associated with DR to nelfinavir, which was not considered for PDR estimation and has not been used since 2013; additionally, N88D and L10F only minimally reduce susceptibility to drugs.


  High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
 PMID: 34212033       2021       BioMed research international
Result: Only half of the individuals had used PI (n = 46/82), only 17% of individuals presented DRMs associated with protease inhibitors (n = 14), and the most frequent mutations were V82A/L/M (6/82; 7.3%) and I54L/M/V (5/82; 6%), L90M (4/82; 4.8%), and M46L/I (4/82; 4.8%) (Figure 1).


  Molecular Network Analysis Reveals Transmission of HIV-1 Drug-Resistant Strains Among Newly Diagnosed HIV-1 Infections in a Moderately HIV Endemic City in China.
 PMID: 35069498       2021       Frontiers in microbiology
Discussion: Only I54L (n = 1), V82A (n = 1), and L90M (n = 5) conferred low or intermediate resistance to LPV/r, suggesting that the low prevalence of these TDRs is related to the fact that LPV/r is not widely used as a second-line drug in China.


  HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial.
 PMID: 34762770       2021       Journal of the International AIDS Society
Result: One sample had the L90M protease inhibitor resistance mutation with no other NRTI or NNRTI mutations.


  Transmitted drug resistance and transmission clusters among HIV-1 treatment-naive patients in Guangdong, China: a cross-sectional study.
 PMID: 34488793       2021       Virology journal
Discussion: The most frequent PI-associated mutation in our study was M46L, whereas it is Q56E in southwest China, M46I in Iceland, and L90M in the south-central United States.



Browser Board

 Co-occurred Entities




   Filtrator